Sufang Chu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 7
- Cancer-related gene regulation 6
- Circular RNAs in diseases 5
- Ubiquitin and proteasome pathways 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Jin Bai (28 shared papers)Pingfu Hou (18 shared papers)Junnian Zheng (16 shared papers)Zhongwei Li (18 shared papers)Minle Li (14 shared papers)Xintian Chen (8 shared papers)Sen Meng (5 shared papers)Hongmei Yong (9 shared papers)
- Journals
- Cell Death and Disease (5 papers)Cell Death Discovery (4 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Journal of Cancer (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaTaiwanUnited Kingdom
In The Last Decade
Sufang Chu
27 papers receiving 784 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 321
- Molecular Biology 580
- Immunology 78
- Oncology 78
- Pulmonary and Respiratory Medicine 76
Countries citing papers authored by Sufang Chu
This map shows the geographic impact of Sufang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sufang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sufang Chu more than expected).
Fields of papers citing papers by Sufang Chu
This network shows the impact of papers produced by Sufang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sufang Chu. The network helps show where Sufang Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sufang Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 165 | |
| 2 | 2019 | 75 | |
| 3 | 2019 | 70 | |
| 4 | 2021 | 62 | |
| 5 | 2020 | 60 | |
| 6 | 2021 | 46 | |
| 7 | 2022 | 40 | |
| 8 | 2022 | 39 | |
| 9 | 2019 | 38 | |
| 10 | 2023 | 29 | |
| 11 | 2022 | 27 | |
| 12 | 2023 | 22 | |
| 13 | 2021 | 14 | |
| 14 | 2024 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2021 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2024 | 8 |
About Sufang Chu
Sufang Chu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Cell Biology and Physiology, having authored 29 papers that have together received 790 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), Ubiquitin and proteasome pathways (3 papers), Microtubule and mitosis dynamics (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (321 citations), Molecular Biology (580 citations), Immunology (78 citations), Oncology (78 citations) and Pulmonary and Respiratory Medicine (76 citations). Sufang Chu has collaborated with scholars based in China, Taiwan and United Kingdom. Frequent co-authors include Jin Bai, Pingfu Hou, Junnian Zheng, Zhongwei Li, Minle Li, Xintian Chen, Sen Meng, Hongmei Yong, Tian Lin and Yuming Gu. Their work appears in journals such as Cell Death and Disease, Cell Death Discovery, Journal of Experimental & Clinical Cancer Research, Journal of Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.